Cargando…

Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective

Whole brain radiotherapy (WBRT) has long been a key treatment of newly diagnosed primary central nervous system lymphoma (PCNSL). In the 1990s, the addition of high dose Methotrexate-based induction chemotherapy (HD MTX-based CT) has enabled a drastic improvement in PCNSL patients outcome. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Alice, Houillier, Caroline, Antoni, Delphine, Hoang-Xuan, Khe, Soussain, Carole, Jacob, Julian, Feuvret, Loic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348332/ https://www.ncbi.nlm.nih.gov/pubmed/37456704 http://dx.doi.org/10.5603/RPOR.a2023.0028

Ejemplares similares

Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma
por: Rozenblum, Laura, et al.
Publicado: (2022)

Mutational analysis of primary central nervous system lymphoma
por: Bruno, Aurélie, et al.
Publicado: (2014)

Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
por: Morales-Martinez, Andrea, et al.
Publicado: (2021)

Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
por: Alcantara, Marion, et al.
Publicado: (2021)

Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
por: Lesueur, Paul, et al.
Publicado: (2022)

S232: EFFICACY AND TOXICITY OF CAR-T CELLS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS, A NEW REFERENCE: THE FRENCH EXPERIENCE OF THE NATIONAL LOC NETWORK
por: Choquet, Sylvain, et al.
Publicado: (2023)

Advances in the treatment of newly diagnosed primary central nervous system lymphomas
por: Qian, Liren, et al.
Publicado: (2017)

SARS-CoV-2 infection in patients with primary central nervous system lymphoma
por: Laurenge, Alice, et al.
Publicado: (2021)

Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience
por: Decavèle, Maxens, et al.
Publicado: (2021)

CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes
por: Lacan, Claire, et al.
Publicado: (2023)

Infection par le SARS-CoV 2 chez les patients avec lymphome cérébral primitif du système nerveux central : étude préliminaire de la sévérité et des facteurs pronostics
por: Laurenge, Alice, et al.
Publicado: (2021)

ML-08 Safety and efficacy of consolidation cytarabine for newly-diagnosed primary central nervous system lymphoma
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients
por: Durand, Thomas, et al.
Publicado: (2015)

Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group
por: Steffanoni, Sara, et al.
Publicado: (2022)

Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma
por: Kuhlman, Justin J, et al.
Publicado: (2022)

Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
por: Yuan, Xianggui, et al.
Publicado: (2022)

Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma
por: Wang, Wei, et al.
Publicado: (2023)

The Efficacy and Safety of Cytarabine on Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2020)

ML-16 First clinical experience of administration of Tirabrutinib for the patients with newly diagnosed primary central nervous system lymphoma
por: Onodera, Sho, et al.
Publicado: (2021)

Symptoms of Depression and Anxiety in Adults with High-Grade Glioma: A Literature Review and Findings in a Group of Patients before Chemoradiotherapy and One Year Later
por: Ribeiro, Monica, et al.
Publicado: (2022)

Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients
por: Birsen, Rudy, et al.
Publicado: (2018)

Case reports: Central nervous system involvement in patients with newly diagnosed multiple myeloma
por: Liu, Jinghua, et al.
Publicado: (2023)

Cranial organs at risk delineation: heterogenous practices in radiotherapy planning
por: Vogin, Guillaume, et al.
Publicado: (2021)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
por: Nguyen, Ludovic T., et al.
Publicado: (2013)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Local Control of Primary Dural Central Nervous System Lymphoma Achieved With Radiotherapy
por: Vallejo, Alexandra, et al.
Publicado: (2021)

P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
por: Shen, Haorui, et al.
Publicado: (2023)

Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors
por: Terziev, Robert, et al.
Publicado: (2021)

Application value of magnetic resonance imaging in diagnosing central nervous system lymphoma
por: Zhang, Shanhua, et al.
Publicado: (2016)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

Tumor Vascular Permeability Pattern Is Associated With Complete Response in Immunocompetent Patients With Newly Diagnosed Primary Central Nervous System Lymphoma: Retrospective Cohort Study
por: Chung, Sae Rom, et al.
Publicado: (2016)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Genetic diversity of newly diagnosed follicular lymphoma
por: Asmann, Y W, et al.
Publicado: (2014)

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
por: Cabannes‐Hamy, Aurélie, et al.
Publicado: (2018)

Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?
por: Wee, Chan Woo
Publicado: (2022)

830. Central Nervous System Involvement in Disseminated Mycobacterium avium Complex Infection in Patients with Newly Diagnosed HIV
por: Camiro, Antonio, et al.
Publicado: (2021)

Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study
por: Li, Qing, et al.
Publicado: (2021)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rj94dear4gvmkomotl9lljfm9n